Foley & Lardner LLP partner Jeff Symons is featured in legal press for his recent arrival to the firm, including in the Bloomberg Law article, “Foley & Lardner Adds M&A Partner Jeff Symons to New York Ranks.”
“Joining Foley presents an exciting opportunity to advance my practice,” Symons said. “The firm’s broad platform, the quality and depth of its lawyers, and its commitment to collaboration and client service will enable me to provide even greater support to new and existing clients on a national scale across critical business sectors.”
Coverage of Symons’ move to Foley also appeared in Attorney at Law Magazine, Bloomberg Law’s Wake Up Call, Legal Desire, New York Law Journal, Reuters, and Westlaw Today.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”